{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG|Withdrawn|" in comments (approximate match)
Status:
Investigational
Source:
NCT01152788: Phase 2 Interventional Completed Melanoma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02550873: Phase 2 Interventional Completed Idiopathic Pulmonary Fibrosis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02535104: Phase 1/Phase 2 Interventional Completed Condylomata Acuminata
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01392547: Phase 3 Interventional Completed Congenital Bleeding Disorder
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00528333: Phase 2 Interventional Completed Acute Myeloid Leukemia
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04311632: Phase 2 Interventional Completed Kidney Transplantation
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00462904: Phase 2 Interventional Terminated Burns
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01110720: Phase 2/Phase 3 Interventional Completed Progressive Supranuclear Palsy
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00322270: Phase 3 Interventional Completed Thrombosis
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02326740: Phase 3 Interventional Terminated Pyoderma Gangrenosum
(2014)
Source URL:
Class:
PROTEIN
